clinical trials

News

Keytruda improves survival in early-stage kidney cancer

MSD’s Keytruda has become the first checkpoint inhibitor to show improved survival when used as adjuvant therapy after surgery to remove tumours in clear cell renal cell c

News

BMS' subcutaneous Opdivo clears first phase 3 trial

Bristol-Myers Squibb is getting closer to offering a subcutaneous version of its cancer immunotherapy Opdivo to patients after it matched the current intravenous formulati

R&D

Take the hybrid road to bring clinical trials to patients

As the landscape of clinical trials evolves, decentralised clinical trials (DCTs) have emerged to put patients at the centre of the research process.

R&D

Abstract laptop with coloured DNA molecule

Understanding the impact of AI on the advancement of gene th...

The biopharmaceutical landscape stands at the cusp of a transformative era, with artificial intelligence (AI) leading the charge.

R&D

This week in clinical trials: 8th-12th January

In our second clinical trials update of 2024, taking in developments in life sciences research and development from early-stage onwards, we look at a wide range of announcements – from onco

Digital

Veeva Systems' Chris Moore interview with Nicole Raleigh

Clinical to medical: Closed loop marketing and connectivity ...

Back at Veeva Commercial Summit in Madrid in November, web editor Nicole Raleigh had a chance to sit down with Veeva Systems’ President Europe, Chris Moore, and have an in-depth conversatio